This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders APAC

Until RNA Leaders APAC

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
October 15-16, 2025
Marina Bay SandsSingapore

A*STAR x Nucleic Acid Therapeutics Initiative (NATi)

Profile

The Nucleic Acid Therapeutics Initiative (NATi) is a national platform that aims to build Singapore into a regional hub for nucleic acid therapeutics (NAT) research, clinical translation, and commercialisation.
NATi harnesses the potential of nucleic acids to treat diseases using RNA molecules. This initiative bolsters strategic partnerships and propels healthcare innovations, benefiting Singapore and Singaporeans.

We're bringing you

  • Keynote Address: Insights into Singapore's journey in mRNA innovation

    8:45am
  • Driving Innovation for the Next-Generation RNA Therapeutics in the Asia-Pacific Region

    9:35am
  • Keynote Address: NATi: Driving Innovation and Translation in RNA Medicine

    9:10am
  • RNA Secondary Structures: Connecting Viral Genomes to mRNA Therapeutics

    12:50pm